psychedelics investing Compass Pathways to Participate in Stifel 2026 Healthcare Conference on November 11th
psychedelics investing Compass Pathways Announces Third Quarter 2026 Financial Results and Business Highlights
psychedelics investing New Joint Survey from Compass Pathways and the Depression and Bipolar Support Alliance Reveals the Lived Burden of Treatment-Resistant Depression on Patients and Caregivers
psychedelics investing Compass Pathways to Highlight Scientific Research and TRD Disease State Education Efforts at the 2026 Neuroscience Education Institute Fall Congress
psychedelics investing Compass Pathways to Announce Third Quarter 2026 Financial Results on November 3, 2026
psychedelics investing Compass Pathways Joins Forces with Leading Mental Health Organizations to Mark First-Ever U.S. Treatment-Resistant Depression Awareness Day
psychedelics investing Compass Pathways to Participate in TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026
psychedelics investing Compass Pathways Launches 'Change the Tune in TRD' in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 2026
psychedelics investing Fluence Selected by Compass Pathways to Develop Post-Approval COMP360 Provider Training
psychedelics investing Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post-Approval COMP360 Provider Training
psychedelics investing Compass Pathways to Participate in Investor Conferences the Week of September 14th
psychedelics investing Compass Pathways' New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial Demonstrates Additional Benefit from Another COMP360 Dose in Part C Extending Durability Out to 1 Year
psychedelics investing Compass Pathways to Debut U.S. HCP Education Campaign and Present New HEOR Data at Psych Congress 2026
Brixton Metals Announces Upsize of Previously Announced Non-Brokered Private Placement to $8 Million and Closing of Second Tranche
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
